The current stock price of AMDA is 0.29 null. In the past month the price increased by 3.57%. In the past year, price decreased by -92.68%.
Amedica Corporation is a commercial biomaterial company. It is focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. The Company market spinal fusion products and are developing products for use in total hip and knee joint replacements. Amedica Corporation is based in Salt Lake City, Utah.
Amedica Corp
1885 WEST 2100 SOUTH
SALT LAKE CITY UT 84119
CEO: B. Sonny Bal
Phone: 801-839-3500
Amedica Corporation is a commercial biomaterial company. It is focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. The Company market spinal fusion products and are developing products for use in total hip and knee joint replacements. Amedica Corporation is based in Salt Lake City, Utah.
The current stock price of AMDA is 0.29 null. The price increased by 7.41% in the last trading session.
AMDA does not pay a dividend.
AMDA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Amedica Corp (AMDA) has a market capitalization of 3.44M null. This makes AMDA a Nano Cap stock.
You can find the ownership structure of Amedica Corp (AMDA) on the Ownership tab.
ChartMill assigns a technical rating of 1 / 10 to AMDA. When comparing the yearly performance of all stocks, AMDA is a bad performer in the overall market: 99.04% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to AMDA. AMDA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months AMDA reported a non-GAAP Earnings per Share(EPS) of -3.13. The EPS increased by 78.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -131.94% | ||
| ROA | -56.73% | ||
| ROE | -113.41% | ||
| Debt/Equity | 0 |